Cargando…
Comparison of two adjuvant hormone therapy regimens in patients with high-risk localized prostate cancer after radical prostatectomy: primary results of study CU1005
The role of adjuvant hormonal therapy and optimized regimens for high-risk localized prostate cancer after radical prostatectomy remains controversial. Herein, the clinical trial CU1005 prospectively evaluated two regimens of maximum androgen blockage or bicalutamide 150 mg daily as immediate adjuva...
Autores principales: | Chang, Kun, Qin, Xiao-Jian, Zhang, Hai-Liang, Dai, Bo, Zhu, Yao, Shi, Guo-Hai, Shen, Yi-Jun, Zhu, Yi-Ying, Ye, Ding-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854103/ https://www.ncbi.nlm.nih.gov/pubmed/26323560 http://dx.doi.org/10.4103/1008-682X.160884 |
Ejemplares similares
-
Pathological Features of Localized Prostate Cancer in China: A Contemporary Analysis of Radical Prostatectomy Specimens
por: Zhu, Yao, et al.
Publicado: (2015) -
Adjuvant hormone therapy after radical prostatectomy in high-risk localized and locally advanced prostate cancer: First multicenter, observational study in China
por: Ye, Dingwei, et al.
Publicado: (2019) -
Serum lipid profiles: novel biomarkers predicting advanced prostate cancer in patients receiving radical prostatectomy
por: Zhang, Gui-Ming, et al.
Publicado: (2015) -
Comparison of the Oncological and Functional Outcomes of Brachytherapy and Radical Prostatectomy for Localized Prostate Cancer
por: Wang, Fei, et al.
Publicado: (2022) -
Comparison of intrafascial and non-intrafascial radical prostatectomy for low risk localized prostate cancer
por: Zhao, Zhankui, et al.
Publicado: (2017)